Published in ASAIO J on March 12, 1996
Treatment data during pediatric home peritoneal teledialysis. Pediatr Nephrol (2003) 0.98
Continuous ambulatory peritoneal dialysis. Ann Intern Med (1978) 5.71
Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med (1980) 4.90
Cross sectional assessment of weekly urea and creatinine clearances and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int (1993) 3.86
Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int (2006) 3.58
OSIRIS trial. Northern Neonatal Nursing Initiative. Lancet (1993) 2.59
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease. J Exp Med (1994) 2.02
Relationships between creatinine clearances and Kt/V in peritoneal dialysis patients: a critique of the DOQI document. Dialysis Outcome Quality Initiative, National Kidney Foundation. Perit Dial Int (1998) 2.00
Continuous ambulatory peritoneal dialysis - 1981. Nephron (1982) 1.82
Peritoneal dialysis for psoriasis. An uncontrolled study. Ann Intern Med (1978) 1.82
Comparison of patient and technique survival in continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis: a multicenter study. Perit Dial Int (1990) 1.70
Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol (1998) 1.70
Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene (2006) 1.68
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol (1995) 1.62
HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading. Immunity (1998) 1.58
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J Exp Med (1995) 1.56
Timely initiation of dialysis: a urea kinetic approach. Am J Kidney Dis (1999) 1.49
Change in the predominance from C 4 to C 3 pathway following anthesis in sorghum. Biochem Biophys Res Commun (1973) 1.46
Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol (1994) 1.44
Controlled sodium removal with peritoneal dialysis. Trans Am Soc Artif Intern Organs (1972) 1.43
Magnetic resonance imaging in Parkinson's disease. Arch Neurol (1990) 1.42
Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: an unusual combination. Am J Kidney Dis (1994) 1.41
Hereditary pancreatitis with lithiasis in a 7-year-old boy. Indian Pediatr (1995) 1.40
Chronic administration of iron dextran into the peritoneal cavity of rats. Perit Dial Int (1997) 1.39
Toward targets for initiation of chronic dialysis. Perit Dial Int (1997) 1.38
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol (1994) 1.35
Calmodulin regulates assembly and trafficking of SK4/IK1 Ca2+-activated K+ channels. J Biol Chem (2001) 1.28
Internalization of the Kv1.4 potassium channel is suppressed by clustering interactions with PSD-95. J Biol Chem (2000) 1.27
Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolution. J Virol (1996) 1.27
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transpl Infect Dis (2007) 1.26
The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans (1992) 1.23
Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol (1997) 1.20
Situs inversus with cholelithiasis. J Postgrad Med (2000) 1.19
Phycobilisome composition and possible relationship to reaction centers. Arch Biochem Biophys (1983) 1.18
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood (2001) 1.18
Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int (1992) 1.17
Reproductive tract infections, gynaecological morbidity and HIV seroprevalence among women in Mumbai, India. Bull World Health Organ (1998) 1.16
Immune surveillance against Epstein-Barr virus. Semin Immunol (1992) 1.16
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine design. Proc Natl Acad Sci U S A (1995) 1.14
Chemical peritonitis after intraperitoneal sodium thiosulfate. Perit Dial Int (2012) 1.14
Unilateral renal vein thrombosis and the nephrotic syndrome. Pediatrics (1972) 1.13
Sodium, potassium and water metabolism in the syndrome of inappropriate antidiuretic hormone secretion. Am J Med (1970) 1.12
Rapid visual assay of cytotoxic T-cell specificity utilizing synthetic peptide induced T-cell-T-cell killing. Immunology (1992) 1.10
Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood (2001) 1.09
The absence of toxicity in intraperitoneal iron dextran administration: a functional and histological analysis. Perit Dial Int (1998) 1.09
Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int (1997) 1.08
Recurrent Rapunzel syndrome. Singapore Med J (2011) 1.08
Suppression of the rat microglia Kv1.3 current by src-family tyrosine kinases and oxygen/glucose deprivation. Eur J Neurosci (2000) 1.08
Preclinical toxicology studies with acyclovir: teratologic, reproductive and neonatal tests. Fundam Appl Toxicol (1984) 1.07
Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J (1993) 1.07
Factors affecting calcium removal with calcium-free peritoneal dialysis. J Lab Clin Med (1971) 1.07
High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int (1983) 1.06
Desmoid tumors: experience of 32 cases and review of the literature. Indian J Cancer (2009) 1.06
Mechanisms of recovery from neutropenia induced by hemodialysis. Blood (1971) 1.05
Giant hydronephrosis masquerading as massive ascites. Postgrad Med J (1993) 1.04
Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis. Kidney Int (1981) 1.04
Fungal peritonitis in patients undergoing chronic intermittent or continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc (1980) 1.04
The peak concentration hypothesis: a urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Perit Dial Int (1989) 1.04
Strategies involved in developing an effective vaccine for EBV-associated diseases. Adv Cancer Res (1996) 1.04
The role of complement, immunoglobulin and bacterial antigen in coagulase-negative staphylococcal shunt nephritis. Am J Med (1975) 1.04
The immunology of Epstein-Barr virus infection. Philos Trans R Soc Lond B Biol Sci (2001) 1.04
Regulation and manipulation of the gene clusters encoding type-I PKSs. Trends Biotechnol (2000) 1.04
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol (1998) 1.03
Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. Proc Natl Acad Sci U S A (1999) 1.03
Four-year experience with swan neck presternal peritoneal dialysis catheter. Am J Kidney Dis (1996) 1.03
Continuous ambulatory peritoneal dialysis: three-year experience at one center. Ann Intern Med (1980) 1.02
Site of bicarbonate effect in Hill reaction. Evidence from the use of artificial electron acceptors and donors. Biochim Biophys Acta (1977) 1.00
Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Eur J Immunol (1995) 1.00
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequences. J Virol (1996) 0.99
Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer. Eur J Cancer (2002) 0.99
Targeting of EBNA1 for rapid intracellular degradation overrides the inhibitory effects of the Gly-Ala repeat domain and restores CD8+ T cell recognition. J Biol Chem (2001) 0.99
Continuous ambulatory peritoneal dialysis in the United States: a three-year study. Kidney Int (1985) 0.99
Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis. Springer Semin Immunopathol (1991) 0.99
Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerization. Neuroscience (2012) 0.98
Peritoneal access and related complications in continuous ambulatory peritoneal dialysis. Am J Med (1983) 0.97
Hemodialysis coil-induced transient neutropenia and overshoot neutrophilia in normal man. Blood (1973) 0.97